Viewing Study NCT02827968


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-24 @ 10:56 AM
Study NCT ID: NCT02827968
Status: COMPLETED
Last Update Posted: 2021-06-02
First Post: 2016-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Sponsor: 3D Medicines (Sichuan) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module